It has been reported that an increased incidence of TP53 mutations is associated with secondary lesions of colorectal tumors, suggesting that mutations in this gene may play an important role in the establishment of colorectal liver metastases [25]. This evidence concerns the gene TP53 and colorectal neoplasm.